TCL Archive NIH, FDA to tighten, review consulting rules as Congressional inquiry continues. May 21, 2004
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA May 23, 1986